Beta-Endorphin During Pregnancy As a Risk Factor for Postpartum Depression

2010 ◽  
Author(s):  
Ilona S. Yim ◽  
Laura M. Glynn ◽  
Christine Dunkel Schetter ◽  
Calvin J. Hobel ◽  
Aleksandra Chicz-Demet ◽  
...  
2021 ◽  
pp. 1-21
Author(s):  
Samar Hameed ◽  
Ihab A. Naser ◽  
Mohamed A. Ghussein ◽  
Mohammed S. Ellulu

Abstract Objective: This study aims to investigate the association between iron body status and postpartum depression (PPD) among mothers during the postpartum period. Design: This is a Case-Control study. Setting: Governmental primary health care centers in the Gaza Strip, Palestine. Participants: This study involved 300 mothers a month after delivery, with one 150 mothers that were recruited in the Cases group who were diagnosed with PPD based on Edinburgh Postnatal Depression Scale (EPDS) ≥10. The Control group included 150 mothers did not have PPD (EPDS <10). Body iron status represented by the index of sTfR/log Ferritin. Results: Among PPD mothers, 43.3% had low ferritin level vs. 15.3% for controls (P<0.001) and cases vs. controls difference in mean hemoglobin level was -0.61 (95% C.I -0.86, -0.35). The results of the Multiple Logistic Regression reported that there is a statistically significant association between PPD and the body iron status existed, as mothers who suffered from iron deficiency (ID) were three times more likely to have PPD (ORadj 3.25; p = 0.015). Furthermore, the results of the final regression model showed that the other factors that can lead to PPD are; absence of psychological guidance services (ORadj 8.54; p = 0.001), suffering from undesired feeling in the last pregnancy (ORadj 1.77; p = 0.034), in addition to having one of the mental health disorders in the last pregnancy (p = 0.001). Conclusion: Body iron status might be a risk factor for postpartum depression and other possibilities of. reverse causality may worsen the condition.


2013 ◽  
Vol 104 (5) ◽  
pp. e375-e387 ◽  
Author(s):  
Caroline Gaudet ◽  
Shi Wu Wen ◽  
Mark C. Walker

2019 ◽  
Vol 259 ◽  
pp. 392-403 ◽  
Author(s):  
Juliana Arantes Figueiredo de Paula Eduardo ◽  
Marcos Gonçalves de Rezende ◽  
Paulo Rossi Menezes ◽  
Cristina Marta Del-Ben

1993 ◽  
Vol 129 (1) ◽  
pp. 26-30 ◽  
Author(s):  
VJM Pop ◽  
HAM de Rooy ◽  
HL Vader ◽  
D van der Heide ◽  
MM van Son ◽  
...  

Rationale—Microsomal antibodies have been related to postpartum thyroid dysfunction and postpartum depression. Objectives—To detect the value of microsomal antibodies during gestation in a random population, as a risk factor for thyroid dysfunction and depression during the postpartum period. Main findings—The presence of microsomal antibodies was investigated in a random population of 293 women at 32 weeks' gestation. At the same time, postpartum thyroid function was assessed repeatedly in all women every six weeks up to 34 weeks' postpartum. Postpartum thyroid dysfunction, defined as the presence of abnormal TSH, in combination with abnormal fT4 and/or fT3 values, occurred in 21 women (7.2%) during the postpartum period. Depression was assessed using the Research Diagnostic Criteria without knowing the results of biochemical thyroid function tests. At 32 weeks' gestation there were 27 (9.2%) women with elevated microsomal antibody titres. Compared with microsomalantibody negative women at 32 weeks' gestation, these women had an RR of 20 for developing postpartum thyroid dysfunction and an RR of 1.7 for developing postpartum depression. Conclusions—Women with elevated microsomal antibody titres during gestation are particularly at risk for postpartum thyroid dysfunction, but only have a slightly increased risk for postpartum depression.


2016 ◽  
Vol 204 ◽  
pp. 54-58 ◽  
Author(s):  
Laura Mandelli ◽  
Daniel Souery ◽  
Lucie Bartova ◽  
Siegfried Kasper ◽  
Stuart Montgomery ◽  
...  

2012 ◽  
Vol 20 (6) ◽  
pp. 419-426 ◽  
Author(s):  
Maryam Rouhi ◽  
Homa Usefi ◽  
Masumeh Hasan ◽  
Maryam Vizheh

Sign in / Sign up

Export Citation Format

Share Document